Australia markets closed

Evoke Pharma, Inc. (EV00.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
1.1700+0.0600 (+5.41%)
At close: 03:35PM CET
Currency in EUR

Valuation measures4

Market cap (intra-day) 4.24M
Enterprise value 3.36M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.99
Price/book (mrq)1.72
Enterprise value/revenue 0.78
Enterprise value/EBITDA -0.47

Trading information

Stock price history

Beta (5Y monthly) 0.27
52-week change 3-25.95%
S&P500 52-week change 314.90%
52-week high 35.4000
52-week low 30.8900
50-day moving average 31.1322
200-day moving average 31.5713

Share statistics

Avg vol (3-month) 312
Avg vol (10-day) 3N/A
Shares outstanding 53.34M
Implied shares outstanding 63.45M
Float 83.25M
% held by insiders 12.46%
% held by institutions 12.07%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 324 May 2022

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023


Profit margin -176.89%
Operating margin (ttm)-102.60%

Management effectiveness

Return on assets (ttm)-42.64%
Return on equity (ttm)-326.59%

Income statement

Revenue (ttm)4.3M
Revenue per share (ttm)1.29
Quarterly revenue growth (yoy)87.80%
Gross profit (ttm)2.14M
Net income avi to common (ttm)-7.61M
Diluted EPS (ttm)-2.0800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.96M
Total cash per share (mrq)1.78
Total debt (mrq)5.01M
Total debt/equity (mrq)N/A
Current ratio (mrq)3.50
Book value per share (mrq)-0.26

Cash flow statement

Operating cash flow (ttm)-6.39M
Levered free cash flow (ttm)-4.12M